Cite Filings / GSK / 0001193125-26-349401
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

GSK plc · Filed 2026-08-13 · Acc 0001193125-26-349401

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-08-20 144 Sale of Securities
  • 2026-08-18 6-K Report of Foreign Issuer
  • 2026-08-13 13F-HR Quarterly Holdings of Institutional Investment Managers
  • 2026-08-13 6-K Report of Foreign Issuer
  • 2026-08-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-08-11 6-K Report of Foreign Issuer
  • 2025-03-07 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2025-12-05 SCHEDULE 13D/A · GSK plc 0.00%
  2. 2025-08-13 SCHEDULE 13D · GSK plc 74%
  3. 2025-03-28 SCHEDULE 13D/A · GSK PLC 16.4%
  4. 2024-11-15 SC 13D/A · GSK plc 9.5%
  5. 2024-11-12 SC 13G/A · GSK plc 11.2%
  6. 2024-03-28 SC 13D/A · GSK plc 4.5%
  7. 2024-02-13 SC 13G/A · Dodge & Cox 5.8%
  8. 2024-02-09 SC 13D/A · GSK plc 11.2%
  9. 2024-02-06 SC 13G/A · GSK plc 7.4%
  10. 2001-05-14 SC 13D/A · GlaxoSmithKline plc 23.7%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…